
Glucagon-like peptide-1 receptor agonist initiation and risk of clinically recorded Alzheimer’s disease-type dementia in older adults with type 2 diabetes: a target trial emulation using causal machine learning
New data suggests popular weight-loss and diabetes drugs might buy older patients a few precious months of cognitive health, but only if doctors target the right individuals.









